Egerton Capital (UK)’s Labcorp LH Stock Holding History

Egerton Capital (UK)’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-978,953	Closed	-$151M	–	31
2018 Q2	$151M	Buy	+978,953	New	+$148M	1.15%	27

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Egerton Capital (UK)'s LH Position: Q3 2018 in Review

Egerton Capital (UK) sold out of Labcorp (LH) in Q3 2018, closing a stake of 978,953 shares — an estimated $151M sold.

Egerton Capital (UK) first reported a position in LH in Q2 2018 and held it in 1 quarter. The position peaked at $151M in Q2 2018. 793 funds tracked by Wall St. Rank hold LH as of Q3 2018.

Egerton Capital (UK) reported no remaining Labcorp position as of Q3 2018 after selling out during the quarter.
Egerton Capital (UK) sold 978,953 Labcorp shares in Q3 2018, an estimated $151M.
Egerton Capital (UK) first reported a position in Labcorp in Q2 2018 and held it in 1 quarter.
Egerton Capital (UK)'s Labcorp position peaked at $151M in Q2 2018.
793 funds tracked by Wall St. Rank held Labcorp as of Q3 2018.

Based on Egerton Capital (UK)'s 13F filing for Q3 2018, filed 13 Nov 2018.